share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Echevarria Joseph

辉瑞 | 4:持股变动声明-董事 Echevarria Joseph
美股sec公告 ·  07/01 20:49
Moomoo AI 已提取核心信息
Joseph Echevarria, a reporting person for Pfizer Inc. [PFE], was involved in a transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer was not specified, and the current number of shares held by Echevarria after the transaction remains undisclosed.
Joseph Echevarria, a reporting person for Pfizer Inc. [PFE], was involved in a transaction on June 28, 2024. The details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Echevarria to Pfizer was not specified, and the current number of shares held by Echevarria after the transaction remains undisclosed.
辉瑞(PFE)的举报人Joseph Echevarria于2024年6月28日参与了一笔交易。交易的细节,包括交易的股份数量、股票类型、交易价格以及股份的总价值,未在公告中披露。Echevarria与辉瑞的关系未予说明,Echevarria在交易后持有的股份数量也未公开。
辉瑞(PFE)的举报人Joseph Echevarria于2024年6月28日参与了一笔交易。交易的细节,包括交易的股份数量、股票类型、交易价格以及股份的总价值,未在公告中披露。Echevarria与辉瑞的关系未予说明,Echevarria在交易后持有的股份数量也未公开。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息